Risk factors for inflammatory breast cancer and other invasive breast cancers

Journal of the National Cancer Institute

Volumn 105, Issue 18, 2013, Pages 1373-1384

  Schairer, Catherine ^c   Li, Yan ^a   Frawley, Peter ^b   Graubard, Barry I ^c   Wellman, Robert D ^b   Buist, Diana S M ^b   Kerlikowske, Karla ^d   Onega, Tracy L ^e   Anderson, William F ^c   Miglioretti, Diana L ^b,f  

^a UNIVERSITY OF MARYLAND   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; ADVANCED CANCER; ARTICLE; BIRTH; BODY MASS; BREAST; BREAST CANCER; CASE CONTROL STUDY; CLIMACTERIUM; CONTROLLED STUDY; DENSITY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY BREAST CANCER; LOCALLY ADVANCED NONINFLAMMATORY BREAST CANCER; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SKIN; THORAX WALL; TUMOR INVASION;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; INFLAMMATORY BREAST NEOPLASMS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; ODDS RATIO; PARTURITION; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, ESTROGEN; RISK ASSESSMENT; RISK FACTORS;

EID: 84886898776     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt206     Document Type: Article

References (24)

1. Anderson WF, Schairer C, Chen BE, Hance KW, Levine PH. Epidemiology of inflammatory breast cancer (IBC). Breast Dis. 2005, 2006;22: 9-23.
2. Greene FL, Page DL, Fritz A, Balch CM, Haller DG, Morrow M. Breast. In: AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002;225-226.
3. Anderson WF, Chu KC, Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities? J Clin Oncol. 2003;21(12): 2254-2259.
4. Chang S, Buzdar AU, Hursting, SD. Inflammatory breast cancer and body mass index. J Clin Oncol. 1998;16(12): 3731-3735.
5. Ballard-Barbash R, Taplin SH, Yankaskas BC, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. Am J Roentgenol. 1997;169(4): 1001-1008.
6. American College of Radiology. Breast imaging reporting and data system (BI-RADS). 4th ed. Reston, VA: American College of Radiology; 2003.
7. Phipps AI, Buist DS, Malone KE, et al. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol. 2012;22(5)340-348.
8. US Census Bureau. Census 2000 ZCTAs. http://www.census.gov/geo/ ZCTA/zcta-brch-vw.pdf. Accessed 17 July 2013.
9. American Joint Committee on Cancer. Manual for Staging of Cancer. 4th ed. Philadelphia: J.B. Lippincott; 1992.
10. American Joint Committee on Cancer. Cancer Staging Manual. 5th ed. Philadelphia Lippincott-Raven; 1997.
11. American Joint Committee on Cancer. Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
12. National Cancer Institute, National Institutes of Health. SEER Program: Comparative Staging Guide for Cancer. Version 1.1. NIH Publication No. 93-3640. Bethesda, MD: National Insitutes of Health; 1993.
13. NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults. Clinical Guideline on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults-The Evidence Report. Bethesda, MD: National Institutes of Health; 1998.
14. World Health Organization. Physical Status: The Use and Intrepretation of Anthropometry. Geneva, Switzerland: World Health Organization; 1995.
15. Raghunathan TE, Lepkowski JM, van Hoewyk M, Solenberger PW. A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodol. 2001;27(1)85-95.
16. Schlichting JA, Soliman AS, Schairer C, et al. Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results Database, 2000-2007. Cancer Epidemiol Biomarkers Prev. 2011;21(1): 155-165.
17. Yaghjyan L, Colditz GA, Collins L, et al. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011;103(15): 1179-1189.
18. Phipps AI, Buist DSM, Malone KE, et al. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol. 2012;22(5): 340-348.
19. Angelo LS, Kurzrock R. Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin Cancer Res. 2007;13(10)2825-2830.
20. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. British J Nutrition. 2004;92(3)347-355.
21. Van Laere S, Ueno N, Finetti P, et al. Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct Affymetrix gene expression data sets [published online ahead of print Feburary 8, 2013]. Clin Cancer Res. doi: 10.1158/1078-0432. CCR-12-2549.
22. Ozturk H, Ozturk H, Guneli E, Yagmur Y, Buyukbayram H. Expression of CD44 and e-cadherin cell adhesion molecules in hypertrophied bladders during chronic partial urethral obstruction and after release of partial obstruction in rats. Urology. 2005;65(5)1013-1018.
23. Perou C, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406(17): 747-752.
24. Althuis MD, Fergenbaum JH, Garcia-Closas M, et al. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2001;13(10): 1558-1568.